SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 45 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $55,402,040 | -15.4% | 2,396,282 | -4.1% | 0.67% | -6.3% |
Q2 2023 | $65,492,132 | +1.7% | 2,497,793 | -0.2% | 0.72% | -1.8% |
Q1 2023 | $64,398,417 | -5.4% | 2,501,881 | -4.4% | 0.73% | -9.9% |
Q4 2022 | $68,046,998 | -6.5% | 2,616,186 | +2.6% | 0.81% | -9.1% |
Q3 2022 | $72,774,000 | -10.3% | 2,550,779 | -22.6% | 0.89% | -3.9% |
Q2 2022 | $81,156,000 | +7.5% | 3,296,350 | +146.4% | 0.93% | +40.5% |
Q1 2022 | $75,505,000 | +9.8% | 1,337,797 | +20.5% | 0.66% | +20.0% |
Q4 2021 | $68,783,000 | -1.7% | 1,109,758 | +0.6% | 0.55% | +0.5% |
Q3 2021 | $69,987,000 | -22.0% | 1,103,204 | +1.3% | 0.55% | -18.8% |
Q2 2021 | $89,706,000 | +6.5% | 1,088,537 | -4.9% | 0.68% | +7.1% |
Q1 2021 | $84,209,000 | -9.9% | 1,144,604 | -11.2% | 0.63% | -13.0% |
Q4 2020 | $93,428,000 | +151.9% | 1,288,300 | +65.6% | 0.72% | +104.5% |
Q3 2020 | $37,087,000 | +1.1% | 778,002 | -10.9% | 0.35% | -6.6% |
Q2 2020 | $36,679,000 | +194.6% | 873,311 | +89.4% | 0.38% | +132.5% |
Q1 2020 | $12,449,000 | -29.4% | 461,071 | +0.7% | 0.16% | +3.8% |
Q4 2019 | $17,631,000 | +98.4% | 458,078 | +11.8% | 0.16% | +76.4% |
Q3 2019 | $8,886,000 | – | 409,892 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |